Skip to contentI
Intelligent Bio Solutions Inc.
I
INBSIntelligent Bio Solutions Inc. Q2 2026 · 10-Q
Revenue$896.77K$896.77K+47.6% vs Q2 2025 Net Income-$2.68M-$2.68MN/M vs Q2 2025 EPS Diluted-$2.82-$2.82N/M vs Q2 2025 Gross Profit$459,739+106.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Intelligent Bio Solutions Inc. · CIK 1725430 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,567,515N/M Free Cash Flowderived-$1,635,747— Margins · derivedGross margin51.3%+14.5 pt vs Q2 2025
Operating margin-293.9%+78.8 pt vs Q2 2025
Net margin-298.6%+71.7 pt vs Q2 2025
ended Dec 31, 2025 · filed Feb 12, 2026 · 43 d after period end